VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
CRD-ACrawford & Company
$11.95$588M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksCRD-AFinancials

Crawford & Company (CRD-A) Financials

30Y historyFree accessUpdated daily

The company struggles with thin underwriting profitability, as demonstrated by a combined ratio that fluctuated between 93.2% and 98.7% over the last ten quarters.

CRD-A Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Revenue1.3B1.31B1.34B1.32B1.23B1.14B1.02B1.05B1.12B1.16B1.18B1.24B1.22B1.25B1.27B1.21B1.11B1.05B1.14B1.05B900.38M854.77M811.66M768.01M757.62M766.27M712.17M701.9M667.3M692.3M633.6M
Revenue Growth %-3.95%-2%1.83%6.96%8.08%12.11%-3%-6.71%-3.5%-1.18%-5.15%2.02%-2.91%-1%4.52%9.05%5.97%-7.72%8.05%16.76%5.34%5.31%5.68%1.37%-1.13%7.6%1.46%5.19%-3.61%9.26%4.28%
Medical Costs & Claims956.47M992.21M973.42M957.85M924.87M847.43M737.32M752.77M808M842.17M850.11M940.35M914.81M936.43M936.06M917.93M839.25M792.33M854.43M809.53M719.03M690.74M643.96M607.44M590.64M587.09M508.83M497.8M479.8M481.2M435.8M
Medical Cost Ratio %73.65%75.5%72.59%72.73%75.12%74.39%72.56%71.86%71.95%72.37%72.19%75.74%75.17%74.71%73.93%75.78%75.55%75.59%75.22%77%79.86%80.81%79.34%79.09%77.96%76.62%71.45%70.92%71.9%69.51%68.78%
Gross Profit342.13M321.9M367.55M359.07M306.35M291.8M278.88M294.85M314.97M321.54M327.48M301.17M302.15M317M330.08M293.43M271.55M255.88M281.49M241.75M181.35M164.03M167.7M160.57M166.98M179.18M203.35M204.1M187.5M211.1M197.8M
Gross Margin %26.35%24.5%27.41%27.27%24.88%25.61%27.44%28.14%28.05%27.63%27.81%24.26%24.83%25.29%26.07%24.22%24.45%24.41%24.78%23%20.14%19.19%20.66%20.91%22.04%23.38%28.55%29.08%28.1%30.49%31.22%
Gross Profit Growth %--12.42%2.36%17.21%4.99%4.64%-5.42%-6.39%-2.04%-1.81%8.74%-0.32%-4.69%-3.96%12.49%8.06%6.13%-9.1%16.44%33.31%10.56%-2.19%4.44%-3.84%-6.81%-11.89%-0.37%8.85%-11.18%6.72%6.63%
Operating Expenses275.99M245.69M299.66M286.51M255.75M244.85M218.95M227.17M242.42M251.75M246.41M276M237.88M232.31M246.64M221.47M202.63M209.46M222.56M207.76M153.19M138.95M135.32M130.53M129.73M126.6M140.98M140.4M129.9M125.9M125.8M
OpEx / Revenue %21.25%18.7%22.35%21.76%20.77%21.49%21.55%21.68%21.59%21.63%20.93%22.23%19.55%18.53%19.48%18.28%18.24%19.98%19.59%19.76%17.01%16.26%16.67%17%17.12%16.52%19.8%20%19.47%18.19%19.85%
Depreciation & Amortization39.98M40.04M36.2M35.74M36.1M40.18M40.11M40.51M44.08M41.66M40.74M43.5M37.64M33.9M32.8M31.82M30.6M31.01M30.33M29.65M20.55M19.18M18.18M16.64M17.73M20.63M20.15M17M14.8M15.4M15.7M
Combined Ratio %94.91%94.2%94.94%94.49%95.89%95.88%94.1%93.54%93.54%94%93.12%97.97%94.72%93.24%93.41%94.06%93.79%95.57%94.81%96.77%96.87%97.07%96.01%96.09%95.08%93.14%91.24%90.92%91.37%87.69%88.64%
Operating Income66.14M76.21M67.88M72.57M50.6M46.95M59.92M67.68M72.55M69.8M81.06M25.17M64.27M84.7M83.44M71.96M68.93M46.42M58.93M33.99M28.16M25.09M32.39M30.04M37.25M52.58M62.37M63.7M57.6M85.2M72M
Operating Margin %5.09%5.8%5.06%5.51%4.11%4.12%5.9%6.46%6.46%6%6.88%2.03%5.28%6.76%6.59%5.94%6.21%4.43%5.19%3.23%3.13%2.93%3.99%3.91%4.92%6.86%8.76%9.08%8.63%12.31%11.36%
Operating Income Growth %-12.26%-6.45%43.4%7.78%-21.65%-11.47%-6.71%3.95%-13.9%222.04%-60.83%-24.12%1.51%15.95%4.4%48.49%-21.23%73.36%20.73%12.24%-22.54%7.81%-19.35%-29.16%-15.69%-2.09%10.59%-32.39%18.33%19.21%
EBITDA106.12M116.25M104.08M108.31M86.7M87.13M100.03M108.2M116.63M111.45M121.8M68.67M101.91M118.6M116.24M103.78M99.53M77.43M89.26M63.64M48.7M44.27M50.56M46.68M54.98M73.21M82.52M80.7M72.4M100.6M87.7M
EBITDA Margin %8.17%8.85%7.76%8.22%7.04%7.65%9.84%10.33%10.39%9.58%10.34%5.53%8.37%9.46%9.18%8.57%8.96%7.39%7.86%6.05%5.41%5.18%6.23%6.08%7.26%9.55%11.59%11.5%10.85%14.53%13.84%
Interest Expense15.81M17.97M20.3M19.81M10.97M6.98M8.19M11.52M11.4M9.91M9.93M8.98M6.81M7.19M9.57M16.93M15.68M14.17M17.62M17.33M8.15M5.14M3.54M5.41M4.71M4.78M4.48M0000
Non-Operating Income17.67M23.64M6.47M5.4M34.59M-3.9M032.53M17.02M17.63M7.89M47.96M-2.43M-3.6M-9.57M-3.4M14.76M145M-3.14M3.98M-1.7M0000000000
Pretax Income32.67M34.6M41.11M47.36M5.05M43.86M39.09M23.64M44.13M42.26M63.24M-31.77M59.89M81.1M83.44M58.43M38.49M-112.75M44.45M21.51M24.07M19.94M37.42M16.63M38.54M47.8M41.15M63.8M43.9M74.7M72M
Pretax Margin %2.52%2.63%3.07%3.6%0.41%3.85%3.85%2.26%3.93%3.63%5.37%-2.56%4.92%6.47%6.59%4.82%3.46%-10.76%3.91%2.05%2.67%2.33%4.61%2.16%5.09%6.24%5.78%9.09%6.58%10.79%11.36%
Income Tax14.82M14.92M14.58M17.1M23.58M13.32M12.01M14.11M18.54M15.04M25.57M13.83M28.78M29.77M33.69M12.74M9.71M2.62M11.56M5.4M9.06M7.06M12.25M8.96M14.03M18.36M15.8M24.5M16.4M27.7M29.2M
Effective Tax Rate %45.36%43.13%35.47%36.1%467.26%30.36%30.73%59.7%42.02%35.59%40.42%-43.53%48.06%36.7%40.37%21.8%25.23%-2.32%26.02%25.08%37.64%35.4%32.74%53.92%36.4%38.4%38.4%38.4%37.36%37.08%40.56%
Net Income17.86M19.63M26.6M30.61M-18.3M30.69M28.3M12.48M25.98M27.66M35.97M-45.49M30.62M50.98M48.89M45.4M28.33M-115.68M32.26M16.12M15.01M12.88M25.17M7.66M24.51M29.45M25.35M39.3M27.5M47M42.8M
Net Margin %1.37%1.49%1.98%2.32%-1.49%2.69%2.78%1.19%2.31%2.38%3.05%-3.66%2.52%4.07%3.86%3.75%2.55%-11.04%2.84%1.53%1.67%1.51%3.1%1%3.24%3.84%3.56%5.6%4.12%6.79%6.76%
Net Income Growth %-41.35%-26.18%-13.11%267.22%-159.64%8.47%126.64%-51.94%-6.1%-23.08%179.07%-248.54%-39.93%4.28%7.67%60.28%124.49%-458.61%100.17%7.36%16.54%-48.83%228.53%-68.74%-16.75%16.16%-35.5%42.91%-41.49%9.81%18.89%
EPS (Diluted)0.360.390.530.62-0.370.570.540.180.500.520.67-0.790.570.930.970.840.53-2.230.620.320.300.260.510.160.500.610.520.780.540.930.84
EPS Growth %-40.12%-26.42%-14.52%267.57%-164.91%5.56%200%-64%-3.85%-22.39%184.81%-238.6%-38.71%-4.12%15.48%58.49%123.77%-459.68%93.75%6.67%15.38%-49.02%218.75%-68%-18.03%17.31%-33.33%44.44%-41.94%10.71%82.61%
EPS (Basic)-0.400.540.63-0.370.580.540.180.510.530.68-0.790.580.950.990.840.54-2.230.630.320.300.260.520.160.500.610.520.780.550.950.84
Diluted Shares Outstanding49.4M50.07M49.74M49.59M49.47M53.98M53.38M54.06M51.96M53.2M53.68M57.58M53.73M55.55M54.24M53.78M53.23M51.83M52.34M50.6M49.58M49.35M49M48.78M48.66M48.56M48.93M50.5M50.94M50.54M51.03M

Key Metrics

Growth RegimeMixed
ProfitabilityStrained
Balance SheetAdequate
Cash FlowStable
Top Statement Risk

High Operating Margin Sensitivity

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Stagnant Revenue Amid Cyclical Headwinds

As indicated by the most recent quarterly data, Crawford & Company experienced a revenue contraction of 1.0% in 2026Q1, following a volatile period where year-over-year growth fluctuated significantly, suggesting that the firm is struggling to maintain consistent top-line momentum in a competitive claims services environment.

The inconsistent revenue trajectory appears to reflect a reliance on event-driven demand, where the absence of major catastrophe activity leaves the firm vulnerable to volume declines. Investors should monitor whether the company can decouple its growth from seasonal weather patterns by expanding its TPA and platform-based service offerings.

Underwriting Efficiency Faces Margin Compression

Based on the reported combined ratio of 96.0% in 2026Q1, Crawford & Company operates with thin underwriting margins, which have fluctuated between 93.2% and 98.7% over the last ten quarters, indicating that the firm lacks the scale to consistently absorb operational costs during periods of lower claim volume.

The proximity of the combined ratio to the 100% break-even threshold suggests that the company's profitability is highly sensitive to minor shifts in loss ratios and administrative expenses. This narrow margin profile implies that any sustained increase in labor costs for field adjusters could rapidly erode the firm's bottom-line performance.

Operational Volatility During Recent Quarters

Financial statements reveal a significant inflection point in 2025Q4, where the company reported a net loss of $7.2 million despite generating $320.9 million in revenue, highlighting the extreme sensitivity of the firm's earnings to fluctuations in operating income and potential non-recurring charges during that specific period.

This quarterly loss underscores the fragility of the current business model, where high fixed costs for professional labor are not sufficiently offset by service fees during quieter claim cycles. The subsequent return to profitability in 2026Q1 warrants further investigation into whether this was driven by cost-cutting measures or a temporary spike in billable adjusting activity.

Structural Risks in Service Delivery

According to the provided income statement data, the company's net margin of 1.49% suggests that the firm is operating as a high-volume, low-reward service provider, which may be unsustainable if competitive pressures in the TPA space continue to force pricing concessions on long-term service contracts.

The reliance on labor-intensive field operations creates a structural disadvantage compared to tech-enabled competitors who may be better positioned to automate claims processing. Investors should be wary of the potential for further margin erosion if the company fails to transition its cost structure toward more scalable, platform-based solutions.

CRD-A — Frequently Asked Questions

Quick answers to the most common questions about buying CRD-A stock.

What was Crawford & Company's (CRD-A) revenue in 2025?

For fiscal year 2025, Crawford & Company (CRD-A) reported total revenue of $1.31B. This represents a 107.4% increase compared to $633.6M in 1996.

Is Crawford & Company (CRD-A) profitable?

Crawford & Company (CRD-A) is profitable, generating $19.6M in net income for the fiscal year ending 2025 with a net profit margin of 1.5%.

What is Crawford & Company's operating profit margin?

Crawford & Company (CRD-A) reported an operating income of $76.2M, resulting in an operating profit margin of 5.8%. This margin reflects the operational efficiency of the business before interest and taxes.

What is Crawford & Company's gross profit and gross margin?

Crawford & Company (CRD-A) generated $321.9M in gross profit for the year, representing a gross profit margin of 24.5%. This demonstrates the company's core pricing power and production efficiency.